Biologics are advanced drugs used in treatment of cancer, rheumatoid arthritis, and other diseases. These biologics constitutes large molecules such as monoclonal antibodies, recombinant proteins and their safety ensures patient safety as these are used in the treatment of different diseases.

Market Analysis and Insights: Global Biologics Safety Testing Market
The global Biologics Safety Testing market size is projected to reach US$ 3976.4 million by 2027, from US$ 2467.4 million in 2020, at a CAGR of 7.0% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biologics Safety Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biologics Safety Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biologics Safety Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biologics Safety Testing market.

Global Biologics Safety Testing Scope and Market Size
Biologics Safety Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biologics Safety Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Endotoxin Tests
Sterility Tests
Cell Line Authentication and Characterization Tests
Bioburden Tests
Cell Line Authentication
Residual Host Contaminant Detection Tests
Adventitious Agent Detection Tests
Others

Segment by Application
Pharmaceutical
Medical Research

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Lonza Group
Charles River
Merck
SGS
WuXi AppTec
Thermo Fisher Scientific
Sartorius
Cytovance Biologics
Pace Analytical Services
Toxikon